Dr. Reddy's Laboratories Ltd (NYSE:RDY) stock is trading lower after the company released third-quarter 2025 earnings. The pharma company clocked a net income of $165 million, marginally up from $161 ...

Dr. Reddy's Laboratories Ltd. 500124 shares inched down 0.54% to 1,289.35 Indian rupees Thursday, on what proved to be an all ...

Dr Reddy's Laboratories reported a 2% increase in net profit to Rs 1,413 crore for the third quarter ending December 2024.

Dr Reddy's Laboratories on Thursday reported a 2% year-on-year growth in its December quarter consolidated net profit at Rs 1 ...

Dr. Reddy's Laboratories' profit rose 2% year-on-year to Rs 1,413.70 crore in the third quarter. That compares with the Rs ...

Pharmaceutical major Dr Reddy's Laboratories Ltd on Thursday (January 23) reported a 2.5% year-on-year (YoY) increase in net ...

Dr. Reddy’s Laboratories (NYSE:RDY – Get Free Report) is expected to be announcing its earnings results on Wednesday, January ...

Dr Reddy's Laboratories posted a 2% rise in net profit for Q3 2024, reaching Rs 1,413 crore, driven by strong market ...

Dr Reddy's Laboratories reported a 2% YoY increase in PAT to ₹1,413.3 crore for Q3 2024, driven by a 16% rise in revenue to ...

Ladies and gentlemen, good day and welcome to the Quarter Three FY 2025 Earnings Conference Call of Dr. Reddy's Laboratories Limited. As a reminder, all participant lines will be in the listen-only ...

Pharma major Dr. Reddy’s Laboratories Ltd. on Thursday announced its consolidated financial results for the quarter and nine ...

Stay up-to-date with the Dr Reddys Stock Liveblog, your comprehensive source for real-time updates and detailed analysis on a ...